SCHEMBL3406384

SCHEMBL3406384

O=C(NCC(O)C(F)(F)F)c1cccc(NS(=O)(=O)CC2CN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)C2)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 2/20 0.39
EGFR P00533 3/20 0.37
FGFR1 P11362 3/20 0.37
KDR P35968 3/20 0.37
UBE2N P61088 1/20 0.37
RHOC P08134 1/20 0.37
RHOA P61586 1/20 0.37
TP53 P04637 2/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
CCR2 P41597 4/20 0.34
ACKR3 P25106 1/20 0.34
KCNH2 Q12809 1/20 0.34
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405536 0.90 PRMT5 (0.41) PRMT5EGFRFGFR1KDRUBE2N
SCHEMBL3406077 0.89 PRMT5 (0.43) PRMT5EGFRFGFR1KDRUBE2N
SCHEMBL3408673 0.86 DRD2 (0.40) EGFRFGFR1KDRTP53LMNA
SCHEMBL979310 0.86 EGFR (0.39) EGFRFGFR1KDRTP53LMNA
SCHEMBL3408729 0.85 EGFR (0.40) PRMT5EGFRFGFR1KDRTP53
Hydrochloric Acid SCHEMBL6527164 0.85 DRD2 (0.40) EGFRFGFR1KDRTP53LMNA
SCHEMBL975803 0.85 EGFR (0.39) PRMT5EGFRFGFR1KDRTP53
SCHEMBL977614 0.84 DRD2 (0.39) EGFRFGFR1KDRLMNADRD2
SCHEMBL3406222 0.84 SCN9A (0.47) EGFRFGFR1KDRLMNADRD2
SCHEMBL977201 0.84 CCR2 (0.40) EGFRFGFR1KDRCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254862-A2 AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME Sanofi-Aventis (FR) 2010-12-01 EP disclosed
WO-2009118473-A2 AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed